Milestone Scientific (MLSS)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $26.64M
Last updated: Nov 17, 2026 at 4:10 PM ET
Milestone Scientific (MLSS) Stock Chart
Milestone Scientific (MLSS) has a latest price of $0.28 on Nov 17, 2026, 51.3% below its 52-week high of $0.58. Its price fell 14.4% over the past 12 months. The month-end price fell 83.5% over the 10 years through Oct 2026, a compound annual decline of 16.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $3.92 in Feb 2021 and its lowest $0.26 in Feb 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MLSS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MLSS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 39.9%, and over 6 months it fell 18.6%. The month-end price fell 65.1% over the 3 years through Oct 2026, a compound annual decline of 29.6%.
| Period | Change |
|---|---|
| 1 month | -15.2% |
| 3 months | -39.9% |
| 6 months | -18.6% |
| 12 months | -14.4% |
| 12 months, with dividends | -14.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -65.1% | -29.6% |
| 5 years | -85.2% | -31.8% |
| 10 years | -83.5% | -16.5% |
Price by Year
Its best calendar year was 2019, when the price rose 319.2%, and its weakest was 2022, when it fell 76.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.30 | +11.6% |
| 2025 | $0.27 | -71.6% |
| 2024 | $0.96 | +39.2% |
| 2023 | $0.69 | +43.7% |
| 2022 | $0.48 | -76.7% |
| 2021 | $2.06 | -2.8% |
| 2020 | $2.12 | +52.5% |
| 2019 | $1.39 | +319.2% |
| 2018 | $0.33 | -71.9% |
| 2017 | $1.18 | -15.6% |
Trading Range
The price is 19.9% below its 50-day average of $0.35 and 20.4% below its 200-day average of $0.36.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.28 | |
| 52-week high | $0.58 | -51.3% |
| 52-week low | $0.22 | +29.6% |
| 50-day average | $0.35 | -19.9% |
| 200-day average | $0.36 | -20.4% |
Price Risk
Over 3 years, its largest fall from a peak was 81.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.26 |
| Largest fall, 1 year | -48.9% |
| Largest fall, 3 years | -81.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MLSS
What is MLSS's 1-year price change?
Milestone Scientific's price fell 14.4% over the past 12 months. With dividends included, the 12-month total return was -14.4%.
What is MLSS's 5-year price change?
Milestone Scientific's month-end price fell 85.2% over the 5 years through Oct 2026, a compound annual decline of 31.8%. These figures leave out dividends.
What is MLSS's 52-week high and low?
Milestone Scientific's 52-week high is $0.58 and its 52-week low is $0.22. Its latest price of $0.28 on Nov 17, 2026 is 51.3% below the high.
What is MLSS's beta?
Milestone Scientific's 1-year beta against the S&P 500 is 1.26, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.9%.
Is the MLSS chart free?
Yes. Advanced Charting for MLSS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MLSS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors